Evidence map›Paper›PMID 22005669›Full record

ArticleThe Analyst2012

Design and development of a field-deployable single-molecule detector (SMD) for the analysis of molecular markers.

Jason M Emory, Zhiyong Peng, Brandon Young, Mateusz L Hupert, Arnold Rousselet, Donald Patterson, Brad Ellison, Steven A Soper

Abstract read
In one paragraph

Article in The Analyst, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jason M EmoryDepartment of Chemistry, Louisiana State University, 232 Choppin Hall, Baton Rouge, LA 70803, USA.
Zhiyong Peng
Brandon Young
Mateusz L Hupert
Arnold Rousselet
Donald Patterson
Brad Ellison
Steven A Soper

Funding

spFRET for Expression Profiling mRNA: Discovering Markers for Stroke DiagnosisR01EB010087 · NIBIB · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI BAIRD, ALISON E, SOPER, STEVEN ALLAN · 2011 to 2014
$2.5M
NIBIB NIH HHS EB-010087NIBIB NIH HHS R01 EB010087
6 · The paper itself

Abstract

Single-molecule detection (SMD) has demonstrated some attractive benefits for many types of biomolecular analyses including enhanced processing speed by eliminating processing steps, elimination of ensemble averaging and single-molecule sensitivity. However, it's wide spread use has been hampered by the complex instrumentation required for its implementation when using fluorescence as the readout modality. We report herein a simple and compact fluorescence single-molecule instrument that is straightforward to operate and consisted of fiber optics directly coupled to a microfluidic device. The integrated fiber optics served as waveguides to deliver the laser excitation light to the sample and collecting the resulting emission, simplifying the optical requirements associated with traditional SMD instruments by eliminating the need for optical alignment and simplification of the optical train. Additionally, the use of a vertical cavity surface emitting laser and a single photon avalanche diode serving as the excitation source and photon transducer, respectively, as well as a field programmable gate array (FPGA) integrated into the processing electronics assisted in reducing the instrument footprint. This small footprint SMD platform was tested using fluorescent microspheres and single AlexaFluor 660 molecules to determine the optimal operating parameters and system performance. As a demonstration of the utility of this instrument for biomolecular analyses, molecular beacons (MBs) were designed to probe bacterial cells for the gene encoding Gram-positive species. The ability to monitor biomarkers using this simple and portable instrument will have a number of important applications, such as strain-specific detection of pathogenic bacteria or the molecular diagnosis of diseases requiring rapid turn-around-times directly at the point-of-use.

Indexed as

BacteriaBacterial InfectionsBiomarkersBiosensing TechniquesEquipment DesignFiber Optic TechnologyFluorescent DyesMicrospheresSpectrometry, FluorescenceTime FactorsBiomarkersFluorescent Dyes

Identifiers

PMID22005669
PMCPMC3278993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.